These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 19479935)

  • 21. Oncogenic ERG Represses PI3K Signaling through Downregulation of IRS2.
    Mao N; Gao D; Hu W; Gadal S; Hieronymus H; Wang S; Lee YS; Sullivan P; Zhang Z; Choi D; Rosen N; Sawyers CL; Gopalan A; Chen Y; Carver BS
    Cancer Res; 2020 Apr; 80(7):1428-1437. PubMed ID: 32015092
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A reduction in Pten tumor suppressor activity promotes ErbB-2-induced mouse prostate adenocarcinoma formation through the activation of signaling cascades downstream of PDK1.
    Rodriguez OC; Lai EW; Vissapragada S; Cromelin C; Avetian M; Salinas P; Ramos H; Kallakury B; Casimiro M; Lisanti MP; Tanowitz HB; Pacak K; Glazer RI; Avantaggiati M; Albanese C
    Am J Pathol; 2009 Jun; 174(6):2051-60. PubMed ID: 19443706
    [TBL] [Abstract][Full Text] [Related]  

  • 23. RUNX3 directly interacts with intracellular domain of Notch1 and suppresses Notch signaling in hepatocellular carcinoma cells.
    Gao J; Chen Y; Wu KC; Liu J; Zhao YQ; Pan YL; Du R; Zheng GR; Xiong YM; Xu HL; Fan DM
    Exp Cell Res; 2010 Jan; 316(2):149-57. PubMed ID: 19800882
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prostate-specific G-protein-coupled receptor collaborates with loss of PTEN to promote prostate cancer progression.
    Rodriguez M; Siwko S; Zeng L; Li J; Yi Z; Liu M
    Oncogene; 2016 Mar; 35(9):1153-62. PubMed ID: 26028029
    [TBL] [Abstract][Full Text] [Related]  

  • 25. PTEN expression controls cellular response to cetuximab by mediating PI3K/AKT and RAS/RAF/MAPK downstream signaling in KRAS wild-type, hormone refractory prostate cancer cells.
    Bouali S; Chrétien AS; Ramacci C; Rouyer M; Becuwe P; Merlin JL
    Oncol Rep; 2009 Mar; 21(3):731-5. PubMed ID: 19212633
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Essential role of Notch signaling in apoptosis of human pancreatic tumoral cells mediated by exosomal nanoparticles.
    Ristorcelli E; Beraud E; Mathieu S; Lombardo D; Verine A
    Int J Cancer; 2009 Sep; 125(5):1016-26. PubMed ID: 19405120
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Protein Kinase C Epsilon Cooperates with PTEN Loss for Prostate Tumorigenesis through the CXCL13-CXCR5 Pathway.
    Garg R; Blando JM; Perez CJ; Abba MC; Benavides F; Kazanietz MG
    Cell Rep; 2017 Apr; 19(2):375-388. PubMed ID: 28402859
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dual Pten/Tp53 suppression promotes sarcoma progression by activating Notch signaling.
    Guijarro MV; Dahiya S; Danielson LS; Segura MF; Vales-Lara FM; Menendez S; Popiolek D; Mittal K; Wei JJ; Zavadil J; Cordon-Cardo C; Pandolfi PP; Hernando E
    Am J Pathol; 2013 Jun; 182(6):2015-27. PubMed ID: 23708211
    [TBL] [Abstract][Full Text] [Related]  

  • 29. PTEN is a protein phosphatase that targets active PTK6 and inhibits PTK6 oncogenic signaling in prostate cancer.
    Wozniak DJ; Kajdacsy-Balla A; Macias V; Ball-Kell S; Zenner ML; Bie W; Tyner AL
    Nat Commun; 2017 Nov; 8(1):1508. PubMed ID: 29142193
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Activation of PI3K-Akt signaling pathway promotes prostate cancer cell invasion.
    Shukla S; Maclennan GT; Hartman DJ; Fu P; Resnick MI; Gupta S
    Int J Cancer; 2007 Oct; 121(7):1424-32. PubMed ID: 17551921
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Regulation of androgen receptor signaling by PTEN (phosphatase and tensin homolog deleted on chromosome 10) tumor suppressor through distinct mechanisms in prostate cancer cells.
    Lin HK; Hu YC; Lee DK; Chang C
    Mol Endocrinol; 2004 Oct; 18(10):2409-23. PubMed ID: 15205473
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gata3 antagonizes cancer progression in Pten-deficient prostates.
    Nguyen AH; Tremblay M; Haigh K; Koumakpayi IH; Paquet M; Pandolfi PP; Mes-Masson AM; Saad F; Haigh JJ; Bouchard M
    Hum Mol Genet; 2013 Jun; 22(12):2400-10. PubMed ID: 23428429
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cooperation between FGF8b overexpression and PTEN deficiency in prostate tumorigenesis.
    Zhong C; Saribekyan G; Liao CP; Cohen MB; Roy-Burman P
    Cancer Res; 2006 Feb; 66(4):2188-94. PubMed ID: 16489020
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Preferential chemosensitization of PTEN-mutated prostate cells by silencing the Akt kinase.
    Priulla M; Calastretti A; Bruno P; Azzariti A; Paradiso A; Canti G; Nicolin A
    Prostate; 2007 May; 67(7):782-9. PubMed ID: 17373720
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Murine cell lines derived from Pten null prostate cancer show the critical role of PTEN in hormone refractory prostate cancer development.
    Jiao J; Wang S; Qiao R; Vivanco I; Watson PA; Sawyers CL; Wu H
    Cancer Res; 2007 Jul; 67(13):6083-91. PubMed ID: 17616663
    [TBL] [Abstract][Full Text] [Related]  

  • 36. RBPJ maintains brain tumor-initiating cells through CDK9-mediated transcriptional elongation.
    Xie Q; Wu Q; Kim L; Miller TE; Liau BB; Mack SC; Yang K; Factor DC; Fang X; Huang Z; Zhou W; Alazem K; Wang X; Bernstein BE; Bao S; Rich JN
    J Clin Invest; 2016 Jul; 126(7):2757-72. PubMed ID: 27322055
    [TBL] [